Conquer Pharmaceutical

Conquer Pharmaceutical Co., Ltd. is a specialty pharmaceutical company based in Taiwan that specializes in the development and manufacture of complex sustained-release injectables. The company leverages its proprietary long-acting microsphere and implant technology platforms to develop treatments for oncology, reproductive health, and central nervous system disorders. Its commercial portfolio includes specialty generics such as Leuprorelin acetate for prostate cancer and endometriosis, and it maintains a pipeline of peptide-based therapeutics including Goserelin and Octreotide. Conquer operates GMP-certified manufacturing facilities in the Zhunan Science Park and provides contract development and manufacturing (CDMO) services to global partners. The company's focus is on delivering difficult-to-formulate specialty medicines that enhance patient adherence through long-term delivery mechanisms.